<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://librepathology.org/w/index.php?action=history&amp;feed=atom&amp;title=Bortezomib</id>
	<title>Bortezomib - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://librepathology.org/w/index.php?action=history&amp;feed=atom&amp;title=Bortezomib"/>
	<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Bortezomib&amp;action=history"/>
	<updated>2026-04-18T14:19:08Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.36.3</generator>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Bortezomib&amp;diff=44972&amp;oldid=prev</id>
		<title>Jensflorian: Drug</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Bortezomib&amp;diff=44972&amp;oldid=prev"/>
		<updated>2016-06-15T13:14:22Z</updated>

		<summary type="html">&lt;p&gt;Drug&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;'''Bortezomib''' is a proteasome inhibitor to treat [[multiple myeloma]] and [[mantle cell lymphoma]]. The substance prevents degradation of pro-apoptotic factors, resulting activation of programmed cell death in neoplastic cells. &amp;lt;ref&amp;gt;{{Cite journal  | last1 = Curran | first1 = MP. | last2 = McKeage | first2 = K. | title = Bortezomib: a review of its use in patients with multiple myeloma. | journal = Drugs | volume = 69 | issue = 7 | pages = 859-88 | month =  | year = 2009 | doi = 10.2165/00003495-200969070-00006 | PMID = 19441872 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Clinical]]&lt;br /&gt;
[[Category:Drugs]]&lt;/div&gt;</summary>
		<author><name>Jensflorian</name></author>
	</entry>
</feed>